| CLBCX | MBNAX | CLBCX / MBNAX | |
| Total Expense Ratio | 1.35 | 1.08 | 125% |
| Annual Report Gross Expense Ratio | 1.35 | 1.08 | 125% |
| Fund Existence | 24 years | 22 years | - |
| Gain YTD | 2.375 | 1.939 | 122% |
| Front Load | N/A | 3% | - |
| Min. Initial Investment | 250 | 15000 | 2% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 270B | 454M | 59,471% |
| Annual Yield % from dividends | 1.19 | 1.96 | 60% |
| Returns for 1 year | 10.51 | 4.96 | 212% |
| Returns for 3 years | 33.67 | 16.86 | 200% |
| Returns for 5 years | 32.27 | 4.14 | 779% |
| Returns for 10 years | 86.26 | 27.62 | 312% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WSBFX | 23.25 | N/A | N/A |
| Boston Trust Walden Balanced | |||
| RLBAX | 37.99 | -0.17 | -0.45% |
| American Funds American Balanced R1 | |||
| PCAQX | 85.82 | -0.63 | -0.73% |
| Principal Capital Appreciation R5 | |||
| VLIIX | 14.09 | -0.23 | -1.61% |
| Value Line Capital Appreciation Instl | |||
| RYCCX | 449.26 | -14.62 | -3.15% |
| Rydex NASDAQ-100® 2x Strategy C | |||